The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition
Open accessAbstract
The biodistribution of approved gadolinium (Gd)‐based contrast agents (GBCAs) is reviewed. After intravenous injection GBCAs distribute in the blood and the extracellular space and transiently through the excretory organs. Preclinical animal studies and the available clinical literature indicate that all these compounds are excreted intact. Elimination tends to be rapid and, for the most part, complete. In renally insufficient patients the plasma elimination half‐life increases substantially from hours to days depending on renal function. In patients with impaired renal function and nephrogenic systemic fibrosis (NSF), the agents gadodiamide, gadoversetamide, and gadopentetate dimeglumine have been shown to result in Gd deposition in the skin and internal organs. In these cases, it is likely that the Gd is no longer present as the GBCA, but this has still not been definitively shown. In preclinical models very small amounts of Gd are retained in the bone and liver, and the amount retained correlates with the kinetic and thermodynamic stability of the GBCA with respect to Gd release in vitro. The pattern of residual Gd deposition in NSF subjects may be different than that observed in preclinical rodent models. GBCAs are designed to be used via intravenous administration. Altering the route of administration and/or the formulation of the GBCA can dramatically alter the biodistribution of the GBCA and can increase the likelihood of Gd deposition. J. Magn. Reson. Imaging 2009;30:1259–1267. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,483
Self-citationRohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H.-J. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,682
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
High, W. A., Ayers, R. A., Chandler, J., Zito, G., & Cowper, S. E. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.047 · Cited by 545
Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C
Frenzel, T., Lengsfeld, P., Schirmer, H., Hütter, J., & Weinmann, H.-J. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181852171 · Cited by 539
Roos, E. M., & Dahlberg, L. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21415 · Cited by 476
Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.
Weinmann, H., Laniado, M., & Mutzel, W. (1984) · PubMed · Cited by 462
MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer, R. B., Parmelee, D. J., Dunham, S. U., Ouellet, H. S., Dolan, R. P., Witte, S., McMurry, T. J., & Walovitch, R. C. (1998) · Radiology · doi:10.1148/radiology.207.2.9577506 · Cited by 457
Gadolinium deposition in nephrogenic fibrosing dermopathy
Boyd, A. S., Zic, J. A., & Abraham, J. L. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.048 · Cited by 373
White, G. W., Gibby, W. A., & Tweedle, M. F. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000186569.32408.95 · Cited by 362
Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis
Eckstein, F., Burstein, D., & Link, T. M. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1063 · Cited by 343
Gadobenate Dimeglumine (Gd-BOPTA): An Overview
KIRCHIN, M. A., PIROVANO, G. P., & SPINAZZI, A. (1998) · Investigative Radiology · doi:10.1097/00004424-199811000-00003 · Cited by 218
Sieber, M. A., Lengsfeld, P., Frenzel, T., Golfier, S., Schmitt-Willich, H., Siegmund, F., Walter, J., Weinmann, H.-J., & Pietsch, H. (2008) · European Radiology · doi:10.1007/s00330-008-0977-y · Cited by 203
Detection and quantification of magnetically labeled cells by cellular MRI
Liu, W., & Frank, J. A. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.09.021 · Cited by 182
Clinical Magnetic Resonance Imaging
Aisen, A. M. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460130134040 · Cited by 179
Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis
High, W. A., Ayers, R. A., & Cowper, S. E. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.01.022 · Cited by 149
Gray, M. L., Burstein, D., Kim, Y., & Maroudas, A. (2007) · Journal of Orthopaedic Research® · doi:10.1002/jor.20482 · Cited by 132
Cabella, C., Crich, S. G., Corpillo, D., Barge, A., Ghirelli, C., Bruno, E., Lorusso, V., Uggeri, F., & Aime, S. (2006) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.88 · Cited by 106
Self-citationCardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis
Swaminathan, S., High, W. A., Ranville, J. F., Horn, T. D., Hiatt, K. M., Thomas, M., Brown, H. H., & Shah, S. V. (2008) · Kidney International · doi:10.1038/ki.2008.76 · Cited by 104
Molecular Mechanisms for the Hepatic Uptake of Magnetic Resonance Imaging Contrast Agents
Pascolo, L., Cupelli, F., Anelli, P. L., Lorusso, V., Visigalli, M., Uggeri, F., & Tiribelli, C. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0454 · Cited by 98
Eldredge-Hindy, H., Spiller, M., Chasse, J. M., et al. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000199293.86956.48 · Cited by 85
MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver
Spinazzi, A., Lorusso, V., Pirovano, G., Taroni, P., Kirchin, M. A., & Davies, A. (1998) · Academic Radiology · doi:10.1016/s1076-6332(98)80069-x · Cited by 80
WAGONER, M. V., O'toole, M., Worah, D., et al. (1991) · Investigative Radiology · doi:10.1097/00004424-199111000-00010 · Cited by 79
Schroeder, J. A., Weingart, C., Coras, B., Haußer, I., Reinhold, S. W., Mack, M., Seybold, V., VOGT, T. M., Banas, B., Hofstaedter, F., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00100108 · Cited by 76
Extracellular MRI Contrast Agents Based on Gadolinium
Gries, H. (2002) · Topics in current chemistry · doi:10.1007/3-540-45733-x_1 · Cited by 66
Pharmacokinetic Behavior of Gadoteridol Injection
McLachlan, S. J., Eaton, S., & Simone, D. N. D. (1992) · Investigative Radiology · doi:10.1097/00004424-199208001-00004 · Cited by 66
WAGONER, M. V., & Worah, D. (1993) · Investigative Radiology · doi:10.1097/00004424-199303001-00005 · Cited by 54
Biodistribution and Clearance of Liposomal Gadolinium-DTPA
Unger, E. C., CARDENAS, D., ZERELLA, A., Fajardo, L. L., & Tilcock, C. (1990) · Investigative Radiology · doi:10.1097/00004424-199006000-00004 · Cited by 46
Feng, Y., Zong, Y., Ke, T., Jeong, E., Parker, D. L., & Lu, Z. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9028-z · Cited by 44
Dose-dependent biodistribution of [153Gd]Gd(acetate)n in mice
Wedeking, P. W., Kumar, K., & Tweedle, M. F. (1993) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(93)90039-w · Cited by 29
Lev, M. H., & Schaefer, P. W. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.173.5.10541135 · Cited by 21
Cited by
Metal–Organic Frameworks in Biomedicine
Horcajada, P., Gref, R., Baati, T., Allan, P. K., Maurin, G., Couvreur, P., Férey, G., Morris, R. E., & Serre, C. (2012) · Chemical Reviews · doi:10.1021/cr200256v · Cited by 4,168
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Self-citationIntracranial gadolinium deposition after contrast-enhanced MR imaging
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2015) · Radiology · doi:10.1148/radiol.15150025 · Cited by 1,358
Kanda, T., Fukusato, T., Matsuda, M., Toyoda, K., Oba, H., Kotoku, J., Haruyama, T., Kitajima, K., & Furui, S. (2015) · Radiology · doi:10.1148/radiol.2015142690 · Cited by 874
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation
Soni, K. S., Desale, S. S., & Bronich, T. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.009 · Cited by 683
Metadata
- Authors
- Aime, S., & Caravan, P.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2009-11-24
- Volume
- 30
- Issue
- 6
- Pages
- 1259-1267
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2133912805
- Cited by
- 534
- References
- 30
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.